Search
for

    Sort by

    Research 181–210 of 1000+

    1. Transcription Regulation and Protein Subcellular Localization of the Truncated Basic Hair Keratin hHb1-ΔN in Human Breast Cancer Cells Journal of Biological Chemistry · 2001 · 8 citations
    2. Novel Insights into TSC22D Family Genes in Metabolic Diseases and Cancer Biomolecules · 2026
    3. A plain language summary of quality of life with sacituzumab govitecan treatment in the TROPiCS-02 study in participants with breast cancer (HR-positive/HER2-negative) Future Oncology · 2025
    4. The stiffness of the extracellular matrix is a key factor in tumor progression MedComm · 2024
    5. Peer Review #1 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.2)" 2023
    6. Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development. PubMed · 2017 · 49 citations
    7. A Transcriptome Sequencing Study on Genome-Wide Gene Expression Differences of Lung Cancer Cells Modulated by Fucoidan Frontiers in Bioengineering and Biotechnology · 2022 · 15 citations
    8. Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer Urology · 2009 · 153 citations
    9. Optimizing treatment management of trastuzumab deruxtecan in clinical practice of breast cancer ESMO Open · 2022 · 60 citations
    10. REV7: a small but mighty regulator of genome maintenance and cancer development Frontiers in Oncology · 2025 · 1 citations
    11. Effectiveness and Safety Profile of Cisplatin Versus Nab-Paclitaxel Concomitant Chemoradiotherapy in Postoperative Early-Stage Cancer of Cervix Biological and Clinical Sciences Research Journal · 2025
    12. Evaluation of Short-Term Efficacy and Long-Term Oncologi-Cal Outcomes of Different Paclitaxels Plus Platinum Regi-Mens in the Treatment of Serous Ovarian Cancer—A Real World Study Research Square (Research Square) · 2021
    13. Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes. Journal of Clinical Oncology · 2018
    14. Formestane Preferred as Second-Line Therapy in Advanced Breast Cancer Drugs & Therapy Perspectives · 1993
    15. The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer 2008 · 108 citations
    16. Exploring the relationship between anastasis and mitochondrial ROS-mediated ferroptosis in metastatic chemoresistant cancers: a call for investigation Frontiers in Immunology · 2024 · 18 citations
    17. Peer Review #4 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.1)" 2023
    18. Peer Review #1 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.1)" 2023
    19. Peer Review #2 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.1)" 2023
    20. Peer Review #4 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.2)" 2023
    21. Peer Review #3 of "Inflammatory auxo-action in the stem cell division theory of cancer (v0.1)" 2023
    22. Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm Asia-Pacific Journal of Clinical Oncology · 2018 · 4 citations
    23. Safety and effectiveness of sacituzumab govitecan in patients with metastatic triple-negative breast cancer in real-world settings: first observations from an interdisciplinary breast cancer centre in Germany Therapeutic Advances in Medical Oncology · 2023 · 34 citations
    24. Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study Annals of Oncology · 2007 · 29 citations
    25. The effectiveness of fermented wheat germ extract as an adjunct therapy in the treatment of cancer: A systematic review JBI Library of Systematic Reviews · 2012 · 5 citations
    26. Phase II trial of paclitaxel poliglumex (CT-2103) in pre- and post-menopausal women on hormonal replacement therapy (HRT) with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology · 2011 · 2 citations
    27. BAYONET trial: staged combination with encorafenib, binimetinib, plus cetuximab following encorafenib plus cetuximab for BRAF V600E-mutant metastatic colorectal cancer ESMO Gastrointestinal Oncology · 2024
    28. S-l Combined with Paclitaxel as Second-line Chemotherapy for Advanced Gastric Cancer Zhongguo quanke yixue · 2012
    29. Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients Journal of Cutaneous Pathology · 2015 · 9 citations
    30. Pharmacological Role and Clinical Applications of 5α-Reductase Inhibitors-Review Article for Pharmacists and Healthcare Professionals 2025